Clinical Toxicology

Salvia divinorum and Mitragyna speciosa (“Kratom”), two unscheduled dietary supplements whose active agents are opioid receptor agonists, have discrete psychoactive effects that have contributed to their increasing popularity. Salvia divinorum contains the highly selective kappa- opioid receptor agonist salvinorin A; this compound produces visual hallucinations and synesthesia. Mitragynine, the major alkaloid identified from Kratom, has been reported as a partial opioid agonist producing similar effects to morphine. An interesting minor alkaloid of Kratom, 7-hydroxymitragynine, has been reported to be more potent than morphine. Both Kratom alkaloids are reported to activate supraspinal mu- and delta- opioid receptors, explaining their use by chronic narcotics users to ameliorate opioid withdrawal symptoms. Despite their widespread Internet availability, use of Salvia divinorum and Kratom represents an emerging trend that escapes traditional methods of toxicologic monitoring. The purpose of this article is to familiarize toxicologists and poison control specialists with these emerging psychoactive dietary supplements.

[1]  K. S. Grewal OBSERVATIONS ON THE PHARMACOLOGY OF MITRAGYNINE , 1932 .

[2]  J. Weisbach,et al.  Some observations on the pharmacology of mitragynine. , 1972, Archives internationales de pharmacodynamie et de therapie.

[3]  E. J. Shellard The alkaloids of Mitragyna with special reference to those of Mitragyna speciosa, Korth. , 1974, Bulletin on narcotics.

[4]  S. Suwanlert A study of kratom eaters in Thailand. , 1975, Bulletin on narcotics.

[5]  K. L. Jansen,et al.  Psychoactive properties of mitragynine (kratom). , 1988, Journal of psychoactive drugs.

[6]  E J Shellard,et al.  Ethnopharmacology of kratom and the Mitragyna alkaloids. , 1989, Journal of ethnopharmacology.

[7]  D J Siebert,et al.  Salvia divinorum and salvinorin A: new pharmacologic findings. , 1994, Journal of ethnopharmacology.

[8]  Shin-ichiro Sakai,et al.  Central antinociceptive effects of mitragynine in mice: contribution of descending noradrenergic and serotonergic systems. , 1996, European journal of pharmacology.

[9]  Kinzo Matsumoto,et al.  Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice. , 1998, Life sciences.

[10]  H. Takayama,et al.  Opioid receptor agonistic characteristics of mitragynine pseudoindoxyl in comparison with mitragynine derived from Thai medicinal plant Mitragyna speciosa. , 1999, General pharmacology.

[11]  K. Hanes Antidepressant effects of the herb Salvia divinorum: a case report. , 2001, Journal of clinical psychopharmacology.

[12]  Bryan L. Roth,et al.  Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Paul Ernsberger,et al.  Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[14]  H. Takayama,et al.  Antinociceptive effect of 7-hydroxymitragynine in mice: Discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa. , 2004, Life sciences.

[15]  Bryan L. Roth,et al.  Salvinorin A: a novel and highly selective kappa-opioid receptor agonist. , 2004, Life sciences.

[16]  Mark S. Schmidt,et al.  A facile method for the preparation of deuterium labeled salvinorin A: synthesis of [2,2,2-2H3]-salvinorin A. , 2004, Bioorganic & medicinal chemistry letters.

[17]  E. Butelman,et al.  Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors , 2005, Psychopharmacology.

[18]  B. Roth,et al.  Salvinorin A: a novel and highly selective kappa-opioid receptor agonist. , 2004, Life sciences.

[19]  H. Takayama Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa. , 2004, Chemical & pharmaceutical bulletin.

[20]  J. Halpern Hallucinogens and dissociative agents naturally growing in the United States. , 2004, Pharmacology & therapeutics.

[21]  E. Boyer,et al.  The Internet and Psychoactive Substance Use Among Innovative Drug Users , 2005, Pediatrics.

[22]  Thomas E Prisinzano,et al.  Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligands. , 2005, Journal of medicinal chemistry.

[23]  T. Prisinzano Psychopharmacology of the hallucinogenic sage Salvia divinorum. , 2005, Life sciences.

[24]  J. Woods,et al.  Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse , 2005, Behavioural pharmacology.

[25]  Amy E. Miller,et al.  Evaluation of Herbal Dietary Supplements Marketed on the Internet for Recreational Use , 2005, The Annals of pharmacotherapy.

[26]  H. Takayama,et al.  Inhibitory effect of mitragynine, an analgesic alkaloid from Thai herbal medicine, on neurogenic contraction of the vas deferens. , 2005, Life sciences.

[27]  Mark S. Schmidt,et al.  Determination of Salvinorin A in body fluids by high performance liquid chromatography-atmospheric pressure chemical ionization. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[28]  C. Gleiter,et al.  Use of nonprohibited hallucinogenic plants: increasing relevance for public health? A case report and literature review on the consumption of Salvia divinorum (Diviner's Sage). , 2005, Pharmacopsychiatry.

[29]  Mark S. Schmidt,et al.  Pharmacokinetics of the plant‐derived κ‐opioid hallucinogen salvinorin A in nonhuman primates , 2005 .

[30]  M. Farré,et al.  Quantification of the plant-derived hallucinogen Salvinorin A in conventional and non-conventional biological fluids by gas chromatography/mass spectrometry after Salvia divinorum smoking. , 2005, Rapid communications in mass spectrometry : RCM.

[31]  Christopher R. McCurdy,et al.  Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist , 2006, Pharmacology Biochemistry and Behavior.

[32]  Cécile Béguin,et al.  Depressive-Like Effects of the κ-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats , 2006, Journal of Pharmacology and Experimental Therapeutics.

[33]  R. Capasso,et al.  The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A inhibit enteric cholinergic transmission in the guinea‐pig ileum , 2006, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[34]  Edward W Boyer,et al.  Self-treatment of opioid withdrawal with a dietary supplement, Kratom. , 2007, The American journal on addictions.